Pediatric Allergy Immunology And Pulmonary Medicine
-
International study supports dupilumab for treatment of moderate-to-severe asthma in children
In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. Read MoreDec 8, 2021
-
Conference explores facts of pediatric allergic diseases
Pediatric allergic diseases — food, drug, seasonal allergies — and anaphylaxis, a potentially life threatening allergic reaction, are on the rise and researchers are working furiously to understand, prevent and treat these conditions. Read MoreSep 28, 2017
-
Pediatric Pulmonary Hypertension program lauded
Monroe Carell Jr. Children’s Hospital at Vanderbilt’s Pediatric Pulmonary Hypertension (PH) program has earned the top level of accreditation from the national Pulmonary Hypertension Association (PHA). Read MoreJun 29, 2017
-
Couple’s gift spurs pediatric allergy research, training
Kathy Delzell Anderson and her husband, Steve, know firsthand how allergies can affect a person’s overall health and well-being. Kathy is a lifelong allergy sufferer, and the couple’s son, Clint, has seasonal allergies. Read MoreOct 6, 2016
-
Pulmonologist Moore always strives to bring his ‘A game’
Paul Moore, M.D., has lived two places in his life: Nashville and Boston. He credits experiences and people in both cities for helping shape him into the physician, pulmonary specialist (and sports fan) that he is today. Read MoreApr 7, 2016